Skip to main content
Clinical Trials/NCT04674332
NCT04674332
Completed
Phase 2

Comparative Study Between Use of Long Acting Insulin Versus Multiple Dose Regimen in Control of Gestational Diabetes Mellitus

Ain Shams University1 site in 1 country148 target enrollmentStarted: September 1, 2019Last updated:

Overview

Phase
Phase 2
Status
Completed
Enrollment
148
Locations
1
Primary Endpoint
time needed to achieve glycemic control

Overview

Brief Summary

multiple dose regimen as a standard treatment for gestational diabetes will be compared to long acting insulin

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to 45 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • pregnant women with gestational diabetes mellitus
  • between 24-28 weeks gestation

Exclusion Criteria

  • other endocrinological abnormalities

Arms & Interventions

long acting insulin

Experimental

Intervention: Long acting insulin (Drug)

multiple dose regimen

Active Comparator

Intervention: multiple dose regimen (Drug)

Outcomes

Primary Outcomes

time needed to achieve glycemic control

Time Frame: 1 year

glycemic control assessed by fasting and postprandial blood sugar

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

maii medhat nawara

associate professor

Ain Shams University

Study Sites (1)

Loading locations...

Similar Trials